Ticker LaunchIPO · CGTX
Cognition Therapeutics Inc
Formerly COGNITION THERAPUTICS INC
Cognition Therapeutics Inc (CGTX) priced its initial public offering on Oct 12, 2021 at $12.00 per share, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $256.5M. B. Riley was lead-left underwriter, joined by Oppenheimer. Troutman Pepper advised the company and McGuireWoods advised the underwriters.
Cognition Therapeutics Inc. is a clinical-stage biopharmaceutical company developing small molecule therapeutics for age-related degenerative diseases of the central nervous system and retina. Its initial work centers on the sigma-2 receptor.
- Status
- IPO
- Ticker
- CGTX
- Exchange
- Nasdaq Global Market
- Priced
- Oct 12, 2021
- IPO price
- $12.00
- Market cap at IPO price
- $256.5M
- First filed
- Jul 19, 2021
- Underwriters
- B. Riley and Oppenheimer
- Company counsel
- Troutman Pepper
- Underwriters' counsel
- McGuireWoods
- Sector
- Biotech & pharma
- Country / state
- NY
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jul 19, 2021
- Latest amendment Oct 4, 2021
- Final prospectus (424B4) Oct 12, 2021
- All filings on EDGAR CIK 1455365
Other Biotech & pharma IPOs in 2021
- Ventyx Biosciences, Inc.VTYX · Oct 21, 2021 · $151.6M
- MiNK Therapeutics, Inc.INKT · Oct 15, 2021 · $40M
- XORTX Therapeutics Inc.XRTX · Oct 14, 2021
- Pyxis Oncology, Inc.PYXS · Oct 8, 2021 · $168M
- Theseus Pharmaceuticals, Inc.THRX · Oct 7, 2021 · $160M
- Exscientia plcEXAI · Oct 4, 2021